Insider holders · CIK 0001273636
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| GLAXOSMITHKLINE PLCrelationship not stated | — | 1,436,448 | 1,436,448 | Feb 24, 2015 · 4:05 pm EST | Form 4 |
| Matthew FeinsodInterim Chief Medical Officer | 50,620 | — | 50,620 | Mar 13, 2019 · 5:16 pm EDT | Form 4 |
| Edward HurwitzDirector | — | 27,472 | 27,472 | May 29, 2018 · 6:57 pm EDT | Form 4 |
| Susan B. WasherPresident and CEO | 22,708 | — | 22,708 | Dec 18, 2018 · 7:36 pm EST | Form 4 |
| Jeffrey D. ChulayVP and Chief Medical Officer | 20,400 | — | 20,400 | Nov 2, 2016 · 6:42 pm EDT | Form 4 |
| Arnold L OronskyDirector | — | 11,208 | 11,208 | Apr 26, 2017 · 1:07 pm EDT | Form 4 |
| William AliskiDirector | 8,500 | 1,500 | 10,000 | Dec 18, 2018 · 8:20 pm EST | Form 4 |
| Lawrence E BullockChief Financial Officer | 10,000 | — | 10,000 | Sep 20, 2016 · 4:51 pm EDT | Form 4 |
| William A. SullivanChief Financial Officer | 3,000 | — | 3,000 | Dec 18, 2018 · 8:10 pm EST | Form 4 |
| Ivana MagovcevicDirector | 3,000 | — | 3,000 | Nov 17, 2016 · 4:53 pm EST | Form 4 |
| Stephen W PotterSee Remarks | 1,400 | — | 1,400 | Sep 27, 2016 · 5:12 pm EDT | Form 4 |
| James RosenDirector | 1,000 | — | 1,000 | Dec 18, 2018 · 8:29 pm EST | Form 4 |
| Mark S ShearmanChief Scientific Officer | 0 | — | 0 | Dec 18, 2018 · 7:58 pm EST | Form 4 |
| Daniel L MenichellaV.P. & Chief Business Officer | 0 | — | 0 | Jan 26, 2015 · 6:04 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.